Shubhra Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 1.95 Cr
as on 03-07-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 03-07-2024
- Revenue 39.76%
(FY 2023)
- Profit 1174.34%
(FY 2023)
- Ebitda -7.60%
(FY 2023)
- Net Worth 1.45%
(FY 2023)
- Total Assets 3.90%
(FY 2023)
About Shubhra Biotech
The Corporate was formerly known as Real India Lifetech Private Limited. The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.95 Cr.
The company currently has active open charges totaling ₹3.00 M.
Venkata Pamuru and Sravanthi Koduru serve as directors at the Company.
- CIN/LLPIN
U33111TG2012PTC083659
- Company No.
083659
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Karkapatla, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Shubhra Biotech Private Limited offer?
Shubhra Biotech Private Limited offers a wide range of products and services, including Prefabricated Houses & Structures, Portable Toilets, Water Treatment & Purification Plant, STP & ETP Tools, Chemical Reactors and Process Tanks, Septic Tanks.
Who are the key members and board of directors at Shubhra Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sravanthi Koduru  | Managing Director | 07-Mar-2013 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Pamuru | Director | 20-Feb-2016 | Current |
Financial Performance of Shubhra Biotech.
Shubhra Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.76% increase. The company also saw a substantial improvement in profitability, with a 1174.34% increase in profit. The company's net worth moved up by a moderate rise of 1.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shubhra Biotech?
In 2023, Shubhra Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Jun 2020 | ₹3.00 M | Open |
How Many Employees Work at Shubhra Biotech?
Shubhra Biotech has a workforce of 9 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shubhra Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shubhra Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
